SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 12, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 2 insiders, $189K total
Actionable Insight • Neutral

No actionable signal from these director sales given the trivial dollar amounts relative to market cap. Continue monitoring for any C-suite open-market transactions or cluster buying activity, which would carry stronger informational content.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$253.25
T+0 close · Jun 12, 2026 · via day close
Latest settled
+13.74%
T+60 · $288.05
Vs SPY
+12.74%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 15 $253.25entry
  2. T+1 · 5mo ago +0.79%α +1.39% · $255.25
  3. T+5 · 5mo ago +3.52%α +4.91% · $262.17
  4. T+20 · 4mo ago +22.11%α +22.86% · $309.25
  5. T+60 · 2mo ago +13.74%α +12.74% · $288.05
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the company's $5.1B market cap. These open-market sales are trivial relative to market cap and likely reflect routine portfolio diversification, no material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Key Facts

  • Director Aryeh Jason sold 5,000 shares total on June 10-11, 2026 (~$1.25M)
  • Director John L. Lamattina sold 257 shares on June 10, 2026 (~$63.5K)
  • Total insider sales of ~$1.31M represent only 0.026% of LGND's $5.1B market cap
  • All sellers are directors, not C-suite executives, signal weight is lower per academic literature

Financial Impact

Negligible, $1.31M is 0.026% of market cap, well below the 0.1% materiality threshold

none

Risk Factors

  • No material risk identified from this insider activity

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LGND-1781299717319

US Market Status

Market Closed · Opens Wed (9h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026